CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials
- PMID: 20346624
- DOI: 10.1016/j.jclinepi.2010.03.004
CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials
Erratum in
- J Clin Epidemiol. 2012 Mar;65(3):351
Abstract
Overwhelming evidence shows the quality of reporting of randomised controlled trials (RCTs) is not optimal. Without transparent reporting, readers cannot judge the reliability and validity of trial findings nor extract information for systematic reviews. Recent methodological analyses indicate that inadequate reporting and design are associated with biased estimates of treatment effects. Such systematic error is seriously damaging to RCTs, which are considered the gold standard for evaluating interventions because of their ability to minimise or avoid bias. A group of scientists and editors developed the CONSORT (Consolidated Standards of Reporting Trials) statement to improve the quality of reporting of RCTs. It was first published in 1996 and updated in 2001. The statement consists of a checklist and flow diagram that authors can use for reporting an RCT. Many leading medical journals and major international editorial groups have endorsed the CONSORT statement. The statement facilitates critical appraisal and interpretation of RCTs. During the 2001 CONSORT revision, it became clear that explanation and elaboration of the principles underlying the CONSORT statement would help investigators and others to write or appraise trial reports. A CONSORT explanation and elaboration article was published in 2001 alongside the 2001 version of the CONSORT statement. After an expert meeting in January 2007, the CONSORT statement has been further revised and is published as the CONSORT 2010 Statement. This update improves the wording and clarity of the previous checklist and incorporates recommendations related to topics that have only recently received recognition, such as selective outcome reporting bias. This explanatory and elaboration document-intended to enhance the use, understanding, and dissemination of the CONSORT statement-has also been extensively revised. It presents the meaning and rationale for each new and updated checklist item providing examples of good reporting and, where possible, references to relevant empirical studies. Several examples of flow diagrams are included. The CONSORT 2010 Statement, this revised explanatory and elaboration document, and the associated website (www.consort-statement.org) should be helpful resources to improve reporting of randomised trials.
Copyright (c) 2010 Moher et al. Published by Elsevier Inc. All rights reserved.
Comment in
-
Updated Consolidated Standards of Reporting Trials (CONSORT): it just gets better.J Clin Epidemiol. 2010 Aug;63(8):813-4. doi: 10.1016/j.jclinepi.2010.01.002. Epub 2010 Mar 25. J Clin Epidemiol. 2010. PMID: 20346626 No abstract available.
Similar articles
-
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.Int J Surg. 2012;10(1):28-55. doi: 10.1016/j.ijsu.2011.10.001. Epub 2011 Oct 12. Int J Surg. 2012. PMID: 22036893 Review.
-
The revised CONSORT statement for reporting randomized trials: explanation and elaboration.Ann Intern Med. 2001 Apr 17;134(8):663-94. doi: 10.7326/0003-4819-134-8-200104170-00012. Ann Intern Med. 2001. PMID: 11304107 Review.
-
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.Cochrane Database Syst Rev. 2012 Nov 14;11(11):MR000030. doi: 10.1002/14651858.MR000030.pub2. Cochrane Database Syst Rev. 2012. PMID: 23152285 Free PMC article. Review.
-
Better reporting of harms in randomized trials: an extension of the CONSORT statement.Ann Intern Med. 2004 Nov 16;141(10):781-8. doi: 10.7326/0003-4819-141-10-200411160-00009. Ann Intern Med. 2004. PMID: 15545678
-
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.Ann Intern Med. 2008 Feb 19;148(4):295-309. doi: 10.7326/0003-4819-148-4-200802190-00008. Ann Intern Med. 2008. PMID: 18283207
Cited by
-
Retirements of professional tennis players in ATP and WTA tour events.Eur J Sport Sci. 2024 Oct;24(10):1526-1536. doi: 10.1002/ejsc.12177. Epub 2024 Sep 22. Eur J Sport Sci. 2024. PMID: 39308146 Free PMC article.
-
Traditional Chinese medicine interventions based on meridian theory for pain relief in patients with primary dysmenorrhea: a systematic review and network meta-analysis.Front Med (Lausanne). 2024 Sep 5;11:1453609. doi: 10.3389/fmed.2024.1453609. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39301491 Free PMC article.
-
Effects of intermittent theta burst stimulation add-on to dialectical behavioral therapy in borderline personality disorder: results of a randomized, sham-controlled pilot trial.Eur Arch Psychiatry Clin Neurosci. 2024 Sep 19. doi: 10.1007/s00406-024-01901-0. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 39297977
-
Recruitment feasibility and dietary and behavioral patterns in toddlers with ASD: Preliminary results from the Autism Eats program.Contemp Clin Trials. 2024 Nov;146:107688. doi: 10.1016/j.cct.2024.107688. Epub 2024 Sep 11. Contemp Clin Trials. 2024. PMID: 39270747
-
Oral mucositis management with photobiomodulation, Bidens pilosa L. (Asteraceae) and Curcuma longa L. (Zingiberaceae), the FITOPROT herbal medicine, and its influence on inflammatory cytokine levels: a randomized clinical trial.Support Care Cancer. 2024 Sep 2;32(9):628. doi: 10.1007/s00520-024-08842-3. Support Care Cancer. 2024. PMID: 39223301 Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
